Article Text

Download PDFPDF
Oxidative stress and airway inflammation in severe exacerbations of COPD
  1. E M Drost1,
  2. K M Skwarski2,
  3. J Sauleda3,
  4. N Soler4,
  5. J Roca4,
  6. A Agusti3,
  7. W MacNee1,2
  1. 1ELEGI/Colt Laboratory, Centre for Inflammation Research, University of Edinburgh, Medical School, Edinburgh EH8 9AG, UK
  2. 2Royal Infirmary Edinburgh, Little France, Edinburgh EH16 4SA, UK
  3. 3Servei de Pneumologia and Unitat d’investigacio, Hospital Universitari son Dureta, Palma de Mallorca, Spain
  4. 4Servei de Pneumologia (ICPCT), Hospital Clinic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain
  1. Correspondence to:
    Dr E M Drost
    ELEGI Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, Medical School, Teviot Place, Edinburgh EH8 9AG, UK; Ellen.Drosted.ac.uk

Abstract

Background: A study was undertaken to assess both oxidative stress and inflammation in the lungs of patients with chronic obstructive pulmonary disease (COPD) during severe and very severe exacerbations compared with those with stable COPD, healthy smokers, and non-smokers. Two sites within the lungs were compared: the large airways (in sputum) and the peripheral airways (by bronchoalveolar lavage (BAL)).

Methods: BAL fluid cell numbers and levels of tumour necrosis factor (TNFα) and interleukin (IL)-8 were measured as markers of airway inflammation and glutathione (GSH) levels as a marker of antioxidant status. Nuclear translocation of the pro-inflammatory transcription factors nuclear factor-κB (NF-κB) and activator protein 1 (AP-1) were also measured by electromobility shift assay in BAL fluid leucocytes and lung biopsy samples.

Results: Influx of inflammatory cells into the peripheral airways during exacerbations of COPD was confirmed. Increased IL-8 levels were detected in BAL fluid from patients with stable COPD compared with non-smokers and healthy smokers, with no further increase during exacerbations. In contrast, IL-8 levels in the large airways increased during exacerbations. GSH levels were increased in the BAL fluid of smokers (444%) and patients with stable COPD (235%) compared with non-smokers and were reduced during exacerbations (severe 89.2%; very severe 52.3% compared with stable COPD). NF-κB DNA binding in BAL leucocytes was decreased in healthy smokers compared with non-smokers (41.3%, n = 9, p<0.001) but did not differ in COPD patients, whereas AP-1 DNA binding was significantly decreased during exacerbations of COPD.

Conclusion: There is evidence of increased oxidative stress in the airways of patients with COPD that is increased further in severe and very severe exacerbations of the disease. This is associated with increased neutrophil influx and IL-8 levels during exacerbations.

  • AP-1, activator protein 1
  • COPD, chronic obstructive pulmonary disease
  • EMSA, electrophoretic mobility shift assay, γ-GCS, gamma-glutamylcysteine synthetase
  • GSH, glutathione
  • IL, interleukin
  • NF-κB, nuclear factor-κB
  • TNFα, tumour necrosis factor α
  • chronic obstructive pulmonary disease
  • nuclear factor-κB
  • interleukin 8
  • oxidative stress
  • glutathione
  • inflammation

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • The study was funded by Novartis Pharmaceutical Company, Horsham, UK, and part funded by FIS 00/0281 and Red Respira (RTIC C03/011 Fondo de Investigacion Sanitaria).

Linked Articles

  • Airwaves
    Wisia Wedzicha